401 related articles for article (PubMed ID: 9356879)
1. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
2. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
[TBL] [Abstract][Full Text] [Related]
3. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study.
Chua RT; Lin HJ; Wang K; Perng CL; Lo WC; Lee CH; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):139-45. PubMed ID: 8634929
[TBL] [Abstract][Full Text] [Related]
4. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
[TBL] [Abstract][Full Text] [Related]
5. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
[TBL] [Abstract][Full Text] [Related]
6. Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
Bour B; Pariente EA; Hamelin B; Garcia E
Gastroenterol Clin Biol; 1993; 17(5):329-33. PubMed ID: 8349066
[TBL] [Abstract][Full Text] [Related]
7. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
Lin HJ; Tseng GY; Hsieh YH; Perng CL; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 1999 Nov; 94(11):3184-8. PubMed ID: 10566712
[TBL] [Abstract][Full Text] [Related]
8. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
Lin HJ; Lo WC; Lee FY; Perng CL; Tseng GY
Arch Intern Med; 1998 Jan; 158(1):54-8. PubMed ID: 9437379
[TBL] [Abstract][Full Text] [Related]
10. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic injection therapy vs. multipolar electrocoagulation vs. laser vs. injection + octreotide vs. injection + omeprazole in the treatment of bleeding peptic ulcers. A prospective randomized study.
Sofia C; Portela F; Gregório C; Rosa A; Camacho E; Tomé L; Ferreira M; Andrade P; Cabral P; Romãozinho J; Gouveia H; Leitão M; Pimenta I; Donato A; Freitas D
Hepatogastroenterology; 2000; 47(35):1332-6. PubMed ID: 11100345
[TBL] [Abstract][Full Text] [Related]
12. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.
Khoshbaten M; Fattahi E; Naderi N; Khaleghian F; Rezailashkajani M
BMC Gastroenterol; 2006 Jan; 6():2. PubMed ID: 16403233
[TBL] [Abstract][Full Text] [Related]
13. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
Mohamed SA; al Karawi MA
Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
[TBL] [Abstract][Full Text] [Related]
15. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
16. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial of endoscopic hemoclip versus heater probe thermocoagulation for peptic ulcer bleeding.
Lin HJ; Hsieh YH; Tseng GY; Perng CL; Chang FY; Lee SD
Am J Gastroenterol; 2002 Sep; 97(9):2250-4. PubMed ID: 12358241
[TBL] [Abstract][Full Text] [Related]
19. [Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding].
Nie Y; Li Y; Sha W; Dai S; She Q; Wu H
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):520-2. PubMed ID: 11809113
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
